CBPO News and Press, China Biologic Products Holdings Inc. From 02/25/19

BEIJING , Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its fourth quarter and fi...

BEIJING , Jan. 7, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) ( "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today reiterated its previously revised full year 2018 forecast. Fu...

China Biologic Products, Inc. (CBPO) Q3 2018 Earnings Conference Call November 2, 2018 7:30 AM ET Executives Samuel Martin – Foote Group David Hui Li – Chairman Bing Li – Chief Executive Officer Ming Yin – Senior Vice President Ming Yang – C...

China Biologic Products (NASDAQ: CBPO ): Q3 Non-GAAP EPS of $0.96 misses by $0.13 ; GAAP EPS of $0.94. Revenue of $119.1M (+19.6% Y/Y) misses by $1.25M . Press Release More news on: China Biologic Products, Inc., Earnings news and commentary, Healthcare stocks news,

3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms; Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms; Net Income Up 4.1% YoY to $32.9 Million Board of Di rectors Ap proves $100 M illion S hare R epurchase P rogram BEIJING , Nov. 1, 2018 /...

AAPL , ACIA , ACLS , AIRG , AIV , ALEX , AMH , ANET , AOSL , APPN , ARCB , ATGE , ATHN , ATR , ATRC , ATSG , BCOV , BFAM , BIO , BL , BLDR , BNFT , BRKR , BVX , CARB , CATM , CBPO , CBS , CC , CCRN , CECO , CERS , CHEF , CNMD , CNXN , CORT , CPS , CPSI ...